2018 Deadlines

Month
Deadline to Submit New Protocol*
Meeting Date
Notify PI By
December
November 28, 2018
December 13, 2018
December 20, 2018

 

2019 Deadlines

Month Deadline to Submit HGT Protocol* Deadline to Submit Non- HGT Protocol Meeting Date Notify PI By
January December 12, 2018** December 12, 2018** January 10, 2019 January 17, 2019
February January 10, 2019 January 30, 2019 February 14, 2019 February 21, 2019
March February 14, 2019 February 27, 2019 March 14, 2019 March 21, 2019
April March 14, 2019 March 27, 2019 April 11, 2019 April 18, 2019
May April 11, 2019 April 24, 2019 May 9, 2019 May 16, 2019
June May 9, 2019 May 29, 2019 June 13, 2019 June 20, 2019
July June 13, 2019 June 26, 2019 July 11, 2019 July 18, 2019
August July 11, 2019 July 24, 2019 August 8, 2019 August 15, 2019
September August 8, 2019 August 28, 2019 September 12, 2019 September 19, 2019
October September 12, 2019 September 25, 2019 October 10, 2019 October 17, 2019
November October 10, 2019 October 30, 2019 November 14, 2019 November 21, 2019
December November 14, 2019 November 27, 2019 December 12, 2019 December 19, 2019

* Any investigator planning to submit a study involving Human Gene Transfer (HGT) or Infectious Agents must contact IBC office prior to submission of the study to discuss study scope and required documentation.  HGT and Infectious Agents is defined as follows:

  1. deliberate transfer of recombinant DNA, or DNA or RNA derived from recombinant DNA into one or more human subjects (in vivo transfer);
  2. deliberate transfer of recombinant DNA, or DNA or RNA derived from recombinant DNA into cells that will be transferred into one or more human subjects (ex vivo transfer);
  3. deliberate transfer of synthetic nucleic acid molecules, or DNA or RNA derived from synthetic nucleic acid molecules, that meet any one of the following criteria:
    1. Contain more than 100 nucleotides; or
    2. Possess biological properties that enable integration into the genome (e.g., cis elements involved in integration); or
    3. Have the potential to replicate in a cell; or
    4. Can be translated or transcribed
  4. infectious agents- any agent that is nonrecombinant in nature that is BSL 2 such as some vaccines or toxins.

** IBC Meetings are held on the second Thursday of the month unless indicated above.

*** Please note that this deadline is earlier than other months due to holiday schedule.

Should you have any questions, please contact the IBC office at oacib@uic.edu